NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Creyos

Creyos

Private
TorontoHealthcare & Life Scienceshttps://creyos.com/

Last Round

Debt

Jul 24, 2023

Total Funding Raised

$16.5M

Company Overview

Creyos is a healthcare technology company that provides a web-based platform for the assessment of brain health and cognitive function.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Healthcare Analytics, Vertical SaaS, Clinical Trials

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

cognitive assessment platformneuropsychological testingbehavioral health assessmentbrain health platformcognitive screeningdementia screeningADHD screeningclinical decision supportconcussion assessmentHIPAA-compliant SaaSeCOAcognitive data collectionfitness-for-duty assessmentmental health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Creyos Comparables

Compare Creyos with similar companies based on industry and business-model similarity.

Creyos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BrainCheck
90%
Neurotrack Technologies, Inc.
88%
CNS Vital Signs
83%

Creyos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
DebtJul 24, 2023
Series AFeb 21, 2023
SeedOct 1, 2021
GrantMar 12, 2021
Growth EquityMar 1, 2021
Seed
Sep 17, 2019

Key People

Founding team and executive leadership

Risto Juola

Chief Technology Officer

Executive Team

Alex Sherrington

Chief Financial Officer

Executive Team

Faraz Shafaghi

Chief Product Officer

Executive Team

Creyos Investors

Notable investors and investment history

Creyos investors
InvestorRounds
The Impact EngineSeed, Series A
Real VenturesSeries A, Seed
Export Development CanadaSeed, Series A
EduLab Capital PartnersSeed, Series A
JFF VenturesSeries A
Canada's Digital Technology SuperclusterGrant
Strada Education FoundationSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 11, 2026

    Attended the 2026 NPA Psychopharmacology Update in Las Vegas.

  • Sep 30, 2025

    Selected as a quarterfinalist for the 2025 Digital Health Awards.

Creyos Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Creyos Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Creyos's valuation, stock price, and market status.

Firmographic Details

HeadquartersToronto
Employee Range96
Year Founded2009
Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.